Stocks

ARK Bolsters AI Computing Power and Precision Medicine Holdings

Guavy AI Editorial Team Published August 31, 2026

Instruments

NVDA

Cathie Wood's investment firm ARK made several changes to its portfolio on August 28, 2026. Despite a market pullback that day, ARK continued to focus on disruptive innovation and rotated capital towards AI computing power and precision medicine sectors.

The firm added to its holdings in NVIDIA (NVDA.US) with the purchase of 243,707 shares. This move reflects ARK's confidence in NVIDIA's irreplaceable role in the global tech arms race and its position as a core asset in the AI computing infrastructure.

ARK also made significant additions to its precision medicine sector, including purchases of Veracyte (VCYT.US) and Intellia Therapeutics (NTLA.US). These moves align with ARK's investment philosophy that prioritizes companies with strong technical moats and long-term growth potential.

ARK Bolsters AI Computing Power and Precision Medicine Holdings

Hamilton Capital Invests $1.33 Million in Walmart

Walmart Sees Significant Institutional Investment Amid E-Commerce Growth

Hayek Kallen Investment Management Acquires $13.3 Million Stake in Walmart Inc.